Pfizer revealed that one of two clinical trials showed an increased cardiovascular risk for patients taking the arthrtitis medication Celebrex. Pfizer is taking steps to discover why there is a discrepancy between the two trials, but is not removing Celebrex from the marketplace. Doctors, however are becoming worried about possible heart attack and stroke for patients using Cox-2 inhibitor drugs, and are advising patients with heart disease not to use drugs such as Celebrex.
Related Tags of Celebrex
Celebrex lawsuit, heart attacks, stroke, Celebrex lawyer, Celebrex attorney